[1] Raja S N, Carr D B, Cohen M, et al. The revised international association for the study of pain definition of pain: concepts, challenges, and compromises[J]. Pain,2020, 161(9):1976-1982.
[2] Goldberg D S, McGee S J. Pain as a global public health priority[J]. BMC Public Health, 2011, 11:770.
[3] Slatyer S, Myers H, Kelly M A. Understanding nurse characteristics that influence assessment and intention to treat pain in postoperative patients: an integrative literature review[J]. Pain Manag Nurs,2022,23(5):663-671.
[4] Sisignano M,Parnham M J,Geisslinger G.Novel approaches to persistent pain therapy[J]. Trends Pharmacol Sci, 2019, 40(6):367-377.
[5] Amini H,Rezabakhsh A,Heidarzadeh M, et al.An examination of the putative role of melatonin in exosome biogenesis[J]. Front Cell Dev Biol, 2021, 9:686.
[6] Mittelbrunn M,Sánchez-Madrid F.Intercellular communication: diverse structures for exchange of genetic information[J]. Nat Rev Mol Cell Biol, 2012, 13(5):328-335.
[7] Ju C,Liu R,Zhang Y,et al.Exosomes may be the potential new direction of research in osteoarthritis management[J].Biomed Res Int, 2019, 19:769.
[8] Jiang L,Shen Y,Guo D,et al. EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance[J]. Nat Commun, 2016, 7:130.
[9] Gupta A, Pulliam L. Exosomes as mediators of neuroinflammation[J]. J Neuroinflammation, 2014,11:68.
[10] Tracey I,Woolf C J,Andrews N A.Composite pain biomarker signatures for objective assessment and effective treatment[J]. Neuron,2019,101(5):783-800.
[11] Reckziegel D,Vachon P E, Petre B,et al.Deconstructing biomarkers for chronic pain: context- and hypothesis-dependent biomarker types in relation to chronic pain[J]. Pain,2019,160 (Suppl 1):S37-S48.
[12] 李琳琳,徐淑秀.癌性神经病理性疼痛护理控制的研究进展[J].蚌埠医学院学报,2015,40(4):558-560.
[13] 黄 玲.癌症疼痛的客观评估及护理干预[J].中国现代药物应用,2011,5(18):103-104.
[14] Sisignano M,Lötsch J, Parnham M J,et al. Potential biomarkers for persistent and neuropathic pain therapy[J]. Pharmacol Ther,2019,199:16-29.
[15] Eldabe S,Obara I,Panwar C,et al.Biomarkers for chronic pain: significance and summary of recent advances[J]. Pain Res Manag,2022, 22:194.
[16] Mussigmann T, Bardel B, Lefaucheur J P. Resting-state electroencephalography (EEG) biomarkers of chronic neuropathic pain, a systematic review [J]. Neuroimage,2022,25(8):351.
[17] PainQx.Current methodology[EB/OL]. (2022-10-15) [2023-02-18].https://painqx.com/core-technology/painqx-solution/.
[18] Tu Y, Cao J, Bi Y,et al.Magnetic resonance imaging for chronic pain: diagnosis, manipulation, and biomarkers[J]. Sci China Life Sci, 2021,64(6):879-896.
[19] Rezaie J, Nejati V, Khaksar M,et al. Diabetic sera disrupted the normal exosome signaling pathway in human mesenchymal stem cells in vitro[J]. Cell Tissue Res, 2018, 374(3):555-565.
[20] Maumus M, Manferdini C, Toupet K,et al.Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis[J]. Stem Cell Res, 2013, 11(2):834-44.
[21] Coughlan C, Bruce K D, Burgy O,et al.Exosome isolation by ultracentrifugation and precipitation and techniques for downstream analyses[J]. Curr Protoc Cell Biol, 2020, 88(1):e110.
[22] D’Agnelli S, Gerra M C, Bignami E, et al. Exosomes as a new pain biomarker opportunity[J]. Mol Pain, 2020, 16:174.
[23] Leoni G, Neumann PA, Kamaly N, et al. Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair[J]. J Clin Invest, 2015, 125(3):1215-1227.
[24] 王艺莹,李瑞青,李婧雯,等.外泌体介导细胞通讯:帕金森病的潜在生物标志物分析[J].中国组织工程研究,2023,27(24):3883-3891.
[25] Dongen H M, Masoumi N, Witwer K W, et al. Extracellular vesicles exploit viral entry routes for cargo delivery[J]. Microbiol Mol Biol Rev, 2016, 80(2):369-386.
[26] Wang H,Chen F S,Zhang Z L,et al. MiR-126-3p-enriched extracellular vesicles from hypoxia-preconditioned VSC 4.1 neurons attenuate ischaemia-reperfusion-induced pain hypersensitivity by regulating the PIK3R2-mediated pathway[J]. Mol Neurobiol, 2021, 58(2):821-834.
[27] Jean T R, Tian Y, Chaudhuri A D, et al. Proteome characterization of small extracellular vesicles from spared nerve injury model of neuropathic pain[J]. J Proteomics, 2020, 21(11):103.
[28] Gurunathan S, Kang M H, Jeyaraj M, et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes[J]. Cells, 2019, 8(4):307.
[29] Kowalski J L, Nguyen N, Battaglino R A, et al. miR-338-5p levels and cigarette smoking are associated with neuropathic pain severity in individuals with spinal cord injury: preliminary findings from a genome-wide microrna expression profiling screen[J]. Arch Phys Med Rehabil, 2022, 103(4):738-746.
[30] Freger S, Leonardi M, Foster W G. Exosomes and their cargo are important regulators of cell function in endometriosis[J]. Reprod Biomed Online, 2021, 43(3):370-378.
[31] Ramanathan S, Shenoda B B, Lin Z, et al. Inflammation potentiates miR-939 expression and packaging into small extracellular vesicles[J]. J Extracell Vesicles, 2019, 8(1):165.
[32] Dietz C, Müller M, Reinhold A K, et al. What is normal trauma healing and what is complex regional pain syndrome I? an analysis of clinical and experimental biomarkers[J]. Pain, 2019, 160(10):2278-2289.
[33] Kim Y H, Kim Y H, Shin Y K, et al. p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathies[J]. Ann Clin Transl Neurol, 2019, 6(7):1292-1301.
[34] Ayoub S S, Yazid S, Flower R J. Increased susceptibility of annexin-A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin-A1[J]. Br J Pharmacol, 2008, 154(5):1135-42.
[35] Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes[J]. Mol Ther, 2010, 18(9):1606-1614.
[36] McIntyre J A, Jones I A, Han B, et al. Intra-articular mesenchymal stem cell therapy for the human joint: a systematic review[J]. Am J Sports Med, 2018, 46(14):3550-3563.
[37] Kozlovskaya L, Abou-Kaoud M, Stepensky D. Quantitative analysis of drug delivery to the brain via nasal route[J]. J Control Release, 2014, 189:133-40.
[38] Pusic K M, Won L, Kraig R P,et al. IFNγ-stimulated dendritic cell exosomes for treatment of migraine modeled using spreading depression[J]. Front Neurosci, 2019, 13:942.
[39] Yuan Q, Wang X, Liu L, et al. Exosomes derived from human placental mesenchymal stromal cells carrying antagomir-4450 alleviate intervertebral disc degeneration through upregulation of ZNF121[J]. Stem Cells Dev, 2020, 29(16):1038-1058.
[40] Jin Z,Ren J,Qi S.Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2[J]. Int Immunopharmacol, 2020, 78:105.
[41] Hsu J M,Shiue S J,Yang K D,et al.Locally applied stem cell exosome-scaffold attenuates nerve injury-induced pain in rats[J]. J Pain Res, 2020, 13:3257-3268.
[42] Console L,Scalise M, Indiveri C. Exosomes in inflammation and role as biomarkers[J]. Clin Chim Acta,2019, 488:165-171.
[43] Toh W S, Lai R C, Hui J H P, et al. MSC exosome as a cell-free MSC therapy for cartilage regeneration: Implications for osteoarthritis treatment[J]. Semin Cell Dev Biol,2017, 67:56-64.